IHH Healthcare
Price target:
UOB Kay Hian “buy” RM5.70

Strong start to FY21 but tightened measures pose headwinds

IHH Healthcare’s 1QFY2021 ended March results were in line with UOB Kay Hian’s estimates, with analyst Philip Wong viewing it as a “strong start to the year”.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook